TY  - JOUR
AU  - Fuentes-Fayos, Antonio C
AU  - Vázquez-Borrego, Mari C
AU  - Jiménez-Vacas, Juan M
AU  - Bejarano, Leire
AU  - Pedraza-Arévalo, Sergio
AU  - L-López, Fernando
AU  - Blanco-Acevedo, Cristóbal
AU  - Sánchez-Sánchez, Rafael
AU  - Reyes, Oscar
AU  - Ventura, Sebastián
AU  - Solivera, Juan
AU  - Breunig, Joshua J
AU  - Blasco, María A
AU  - Gahete, Manuel D
AU  - Castaño, Justo P
AU  - Luque, Raúl M
AU  - Blasco, MA
PY  - 2020
DO  - 10.1093/brain/awaa273
UR  - http://hdl.handle.net/20.500.12105/18182
AB  - Glioblastomas remain the deadliest brain tumour, with a dismal ∼12-16-month survival from diagnosis. Therefore, identification of new diagnostic, prognostic and therapeutic tools to tackle glioblastomas is urgently needed. Emerging evidence indicates...
LA  - eng
PB  - Oxford University Press
KW  - Alternative Splicing
KW  - Apoptosis
KW  - Biomarkers, Tumor
KW  - Brain Neoplasms
KW  - Cell Movement
KW  - Cell Proliferation
KW  - Gene Expression Regulation, Neoplastic
KW  - Gene Silencing
KW  - Glioblastoma
KW  - Humans
KW  - Neoplasm Invasiveness
KW  - Receptor, Platelet-Derived Growth Factor beta
KW  - Serine-Arginine Splicing Factors
KW  - Signal Transduction
KW  - Survival Analysis
KW  - Xenograft Model Antitumor Assays
TI  - Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
TY  - journal article
ER  -